GPRP acetate
CAS No. 157009-81-9
GPRP acetate( —— )
Catalog No. M29759 CAS No. 157009-81-9
GPRP acetate is fibrinogen-related peptides, which inhibit the interaction of fibrinogen with the platelet membrane glycoprotein IIbIIIa complex (GPIIbIIIa).
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
2MG | 41 | In Stock |
|
5MG | 65 | In Stock |
|
10MG | 102 | In Stock |
|
25MG | 205 | In Stock |
|
50MG | 335 | In Stock |
|
100MG | 537 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
Biological Information
-
Product NameGPRP acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionGPRP acetate is fibrinogen-related peptides, which inhibit the interaction of fibrinogen with the platelet membrane glycoprotein IIbIIIa complex (GPIIbIIIa).
-
DescriptionGPRP acetate is fibrinogen-related peptides, which inhibit the interaction of fibrinogen with the platelet membrane glycoprotein IIbIIIa complex (GPIIbIIIa).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number157009-81-9
-
Formula Weight485.53
-
Molecular FormulaC20H35N7O7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 125 mg/mL (268.93 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Hecogenin
Hecogenin is a steroid saponin isolated from Agave sisalana. It is a selective inhibitor of human UDP-glucuronosyltransferases. Hecogenin has a wide spectrum of pharmacological activities including anti-inflammatory antifungal and gastroprotective effects.
-
1-Octadecanol
Octadenol is a fatty alcohol present in human and is normally incorporated into plasmalogen lipids. Sjogren-Larsson syndrome is defined by the triad of ichthyosis mental retardation and spasticity and patients accumulate fatty alcohols such as Octadenol in the plasma and cultured fibroblasts.
-
OGT-IN-2
OGT-IN-2 is a potent O-GlcNAc transferase (OGT) inhibitor. OGT-IN-2 inhibits sOGT and ncOGT with IC50 values of 30 μM and 53 μM, respectively. OGT-IN-2 can be used for the research of articular diseases.